Table 2 Disease factors according to lung cancer type
From: A 10-year retrospective study of lung cancer in Uganda
Variable | Female (n = 117) | Male (n = 90) | Overall (N = 207) | P-value |
|---|---|---|---|---|
Stage | n/a | |||
IIIB IIIC IVA IVB Limited Extensive Unknown | 2 2 59 51 0 (0.0) 3 (100.0) 0 (0.0) | 1 (1.5) 2 (2.0) 43 (51.0) 39 (45.0) 0 4 1 (0.5) | 3 (1.4) 4 (1.9) 102 (49.3) 90 (43.5) 0 (0.0) 7 (3.4) 1 (0.5) | |
Histologic type | .471 | |||
NSCLC SCLC | 114 3 | 86 4 | 200 7 | |
Liver metastases Unknown | 12 (14.3) 15 (0.0) | 18 (14.5) 9 (12.0) | 30 (14.5) 24 (11.6) | .071 |
Contralateral lung metastases Unknown | 36 (14.3) 10 (0.0) | 26 (30.5) 7 (8.5) | 62 (30.0) 17 (8.2) | .757 |
Brain metastases Unknown | 12 (14.3) 17 (0.0) | 8 (9.5) 10 (13.5) | 20 (9.7) 27 (13.0) | .812 |
Bone metastases Unknown | 23 (42.9) 15 (0.0) | 21 (20.5) 8 (11.5) | 44 (21.3) 23 (11.1) | .728 |
Pleural Metastases** Unknown | 88 (28.6) 6 (0.0) | 70 (78.0) 3 (4.5) | 158 (76.3) 9 (4.3) | .861 |